Tetraphase antibiotic gets FDA QIDP designation

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 22 Jul, 2013

Singapore: US-based Tetraphase Pharmaceuticals has received approval from US FDA for its lead antibiotic product candida...Read more

Zhejiang Medicine, Ambrx to develop antibody drug conjugate for breast cancer

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaborati...Read more

Novartis to ship 30 mn flu vaccine to US

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

Singapore: Novartis plans to ship around 30 million doses of its influenza vaccines including Fluvirin and Flucelvax to ...Read more

FDA warns Genentech researcher for trial data validity

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

Singapore: The US FDA has given a warning to Dr Bernard Doft, a phase III investigator of Genentech's Lucentis macular d...Read more

Pall to acquire Atmi for $185 million

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Feb, 2014

Singapore: Pall Corporation, a developer of filtration, separation and purification technology, has decided to acquire A...Read more

Now 9-yr-old girls can use Cervarix for cancer

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

Singapore: Cervarix has now been approved for use in females aged nine-to-25 years to prevent persistent infection, prem...Read more

Novotech to support drug development in Korea

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2014

Singapore: Australian clinical research organization, Novotech, has partnered with Korea Drug Development Fund (KDDF) to...Read more

Xiangxue Pharma acquires rights for Kinex KX02

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceut...Read more

Alchemia appoints new chairman

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Feb, 2014

Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-exe...Read more

Bionomics, Merck Serono end agreement

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended t...Read more

Chinese, Hong Kong scientists map H7N9 risk infection

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production ...Read more

AstraZeneca, Alchemia sign $240 mn drug deal

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Apr, 2013

Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the...Read more

Takeda gets Japanese NDA approval for obesity drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

Singapore: Japan-based Takeda Pharmaceutical and Amsterdam-based Norgine has received Japanese Ministry of Health, Labo...Read more

Lilly reveals phase III trial data on back pain

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

Singapore: Eli Lilly and Company published data from a phase III trial comparing the effects of FORTEO (teriparatide, rD...Read more

Takeda's diabetes drug gets Chinese FDA nod

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 01 Aug, 2013

Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has ...Read more

Aveo, Astellas report cancer trial results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Feb, 2013

Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, fr...Read more

UK, Belgium nod for Bone Therapeutics' therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2013

Singapore: Europe-based Bone Therapeutics, a biopharmaceutical company focused on innovative cell therapy products for t...Read more

Japan, Singapore to bring innovation in drug, device, technology

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2013

Singapore: Japan's Kanagawa Prefecture's Global Collaboration Center for Life Innovation (GCC) and the Agency for Scienc...Read more